Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01887886
Title A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating EGFR Mutation
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Bakersfield California 93309 United States Details
Fullerton California 92835 United States Details
Long Beach California 90813 United States Details
Los Angeles California 90095-1772 United States Details
Los Angeles California 90095 United States Details
San Luis Obispo California 93454 United States Details
Fort Myers Florida 33905 United States Details
Orlando Florida 32803 United States Details
Saint Petersburg Florida 33705 United States Details
Chicago Illinois 60637 United States Details
Marrero Louisiana 70072 United States Details
Metairie Louisiana 70006 United States Details
St. Louis Missouri 63110 United States Details
Canton Ohio 44718 United States Details
Nashville Tennessee 37203 United States Details
Caen 14076 France Details
Lyon 69373 France Details
Nantes 44805 France Details
Grosshansdorf 22927 Germany Details
Oldenburg 26121 Germany Details
Villingen-Schwenningen 78052 Germany Details
Ehime 791-0280 Japan Details
Okayama 700-8558 Japan Details
Yamaguchi 755-0241 Japan Details
Gwangju 501-757 Korea, Republic of Details
Suwon-si, 442-723 Korea, Republic of Details
Tanjung Bungah 11200 Malaysia Details
Barcelona 08025 Spain Details
Barcelona 08035 Spain Details
Madrid 28007 Spain Details
Madrid 28050 Spain Details
Madrid 28222 Spain Details
Taichung 40447 Taiwan Details
Taipei 00112 Taiwan Details
Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field